These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3780820)

  • 1. 2-Mercaptopropionate, a novel metabolite formed during treatment with 2-mercaptopropionyl-glycine in cystinuria.
    Mårtensson J; Denneberg T; Kågedal B
    Eur J Clin Pharmacol; 1986; 31(1):119-21. PubMed ID: 3780820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cystinuria with alpha-mercaptopropionylglycine.
    Johansen K; Gammelgård PA; Jørgensen FS
    Scand J Urol Nephrol; 1980; 14(2):189-92. PubMed ID: 7209424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatography of 2-mercaptopropionylglycine and its metabolite 2-mercaptopropionic acid in plasma and urine after treatment with thiopronine.
    Kågedal B; Andersson T; Carlsson M; Denneberg T; Hoppe A
    J Chromatogr; 1987 Jul; 417(2):261-7. PubMed ID: 3654879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfur amino acid metabolism in cystinuria: a biochemical and clinical study of patients.
    Mårtensson J; Denneberg T; Lindell A; Textorius O
    Kidney Int; 1990 Jan; 37(1):143-9. PubMed ID: 2299801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myopathy due to mercaptopropionyl glycine.
    Hales DS; Scott R; Lewi HJ
    Br Med J (Clin Res Ed); 1982 Oct; 285(6346):939. PubMed ID: 6811078
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotic syndrome during treatment with alpha-mercaptopropionylglycine.
    Rizzoni G; Pavanello L; Dussini N; Chiandetti L; Zacchello G
    J Urol; 1979 Sep; 122(3):381-2. PubMed ID: 470014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria.
    Harbar JA; Cusworth DC; Lawes LC; Wrong OM
    J Urol; 1986 Jul; 136(1):146-9. PubMed ID: 3712602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystinuria in children.
    Pavanello L; Rizzoni G; Dussini N; Zacchello G; Passerini G; Tasca A; Pagano F
    Eur Urol; 1981; 7(3):139-43. PubMed ID: 7202450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sodium intake on cystinuria with and without tiopronin treatment.
    Lindell A; Denneberg T; Edholm E; Jeppsson JO
    Nephron; 1995; 71(4):407-15. PubMed ID: 8587620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mercaptopropionylglycine: a progress in cystine stone therapy.
    Hautmann R; Terhorst B; Stuhlsatz HW; Lutzeyer W
    J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotic syndrome occurring during tiopronin treatment for cystinuria.
    Tasic V; Lozanovski VJ; Ristoska-Bojkovska N; Sahpazova E; Gucev Z
    Eur J Pediatr; 2011 Feb; 170(2):247-9. PubMed ID: 20924604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds.
    Fjellstedt E; Harnevik L; Jeppsson JO; Tiselius HG; Söderkvist P; Denneberg T
    Urol Res; 2003 Dec; 31(6):417-25. PubMed ID: 14586528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of free cystine and the tiopronin-cysteine-mixed disulfide during long term tiopronin treatment of cystinuria.
    Lindell A; Denneberg T; Jeppsson JO
    Nephron; 1995; 71(3):328-42. PubMed ID: 8569983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myopathy due to mercaptopropionyl glycine.
    Mansell MA
    Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1356-7. PubMed ID: 6812710
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine.
    Pak CY; Fuller C; Sakhaee K; Zerwekh JE; Adams BV
    J Urol; 1986 Nov; 136(5):1003-8. PubMed ID: 3534301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemphigus foliaceus and proteinuria induced by alpha-mercaptopropionylglycine.
    Lucky PA; Skovby F; Thier SO
    J Am Acad Dermatol; 1983 May; 8(5):667-72. PubMed ID: 6863624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of treatment of cystinuria and cystine lithiasis with alpha-mercaptopropionylglycine. Apropos of 40 patients].
    Giannakopoulos X; Kalfakakou V; Tsoumanis P; Karkabounas S; Giannakis D; Chambilomatis P; Evangelou A; Kallistratos G
    J Urol (Paris); 1994; 100(3):129-34. PubMed ID: 7836789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical Modification of Tiopronin for Dual Management of Cystinuria and Associated Bacterial Infections.
    Kumar A; Estes Bright LM; Garren MRS; Manuel J; Shome A; Handa H
    ACS Appl Mater Interfaces; 2023 Sep; 15(37):43332-43344. PubMed ID: 37671841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cystinuria with Thiola (alpha-mercaptopropionyl glycine).
    Remien A; Kallistratos G; Burchardt P
    Eur Urol; 1975; 1(5):227-8. PubMed ID: 1233187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.
    Mikel CC; Goldfarb DS; Ponte A; Steigelman K; Latyshev S
    Urolithiasis; 2022 Dec; 50(6):721-727. PubMed ID: 36201021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.